Regeneron Pharmaceuticals · Total Current Liabilities

Latest reported$4.37Bperiod endingDec 31, 2025

REGN FY Current Liabilities ($1.80M → $4.37B)

Annual total current liabilities

High-resolution chart · PNG

REGN total current liabilities history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Total Current Liabilities — Annual fiscal periods (USD)
Period ending	Total Current Liabilities (USD)
Dec 31, 2025	4,368,400,000
Dec 31, 2024	3,944,300,000
Dec 31, 2023	3,423,400,000
Dec 31, 2022	3,141,300,000
Dec 31, 2021	3,932,500,000
Dec 31, 2020	2,697,400,000
Dec 31, 2019	2,096,600,000
Dec 31, 2018	1,442,800,000
Dec 31, 2017	1,135,483,000
Dec 31, 2016	1,241,495,000
Dec 31, 2015	811,162,000
Dec 31, 2014	654,660,000
Dec 31, 2013	298,835,000
Dec 31, 2012	163,550,000
Dec 31, 2011	148,271,000
Dec 31, 2010	109,056,000
Dec 31, 2009	93,575,000
Dec 31, 2008	83,672,000
Dec 31, 2007	283,664,000
Dec 31, 2006	45,014,000
Dec 31, 2005	40,357,000
Dec 31, 2004	34,139,000
Dec 31, 2003	72,923,000
Dec 31, 2002	40,118,000
Dec 31, 2001	22,022,000
Dec 31, 2000	13,786,000
Dec 31, 1999	13,300,000
Dec 31, 1998	9,400,000
Dec 31, 1997	10,700,000
Dec 31, 1996	12,000,000
Dec 31, 1995	12,900,000
Dec 31, 1994	17,900,000
Dec 31, 1993	13,100,000
Dec 31, 1992	4,600,000
Dec 31, 1991	3,300,000
Dec 31, 1990	1,800,000